Literature DB >> 20382168

Optimal control for pandemic influenza: the role of limited antiviral treatment and isolation.

Sunmi Lee1, Gerardo Chowell, Carlos Castillo-Chávez.   

Abstract

The implementation of optimal control strategies involving antiviral treatment and/or isolation measures can reduce significantly the number of clinical cases of influenza. Pandemic-level control measures must be carefully assessed specially in resource-limited situations. A model for the transmission dynamics of influenza is used to evaluate the impact of isolation and/or antiviral drug delivery measures during an influenza pandemic. Five pre-selected control strategies involving antiviral treatment and isolation are tested under the "unlimited" resource assumption followed by an exploration of the impact of these "optimal" policies when resources are limited in the context of a 1918-type influenza pandemic scenario. The implementation of antiviral treatment at the start of a pandemic tends to reduce the magnitude of epidemic peaks, spreading the maximal impact of an outbreak over an extended window in time. Hence, the controls' timing and intensity can reduce the pressures placed on the health care infrastructure by a pandemic reducing the stress put on the system during epidemic peaks. The role of isolation strategies is highlighted in this study particularly when access to antiviral resources is limited. (c) 2010 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20382168     DOI: 10.1016/j.jtbi.2010.04.003

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  24 in total

1.  React or wait: which optimal culling strategy to control infectious diseases in wildlife.

Authors:  Luca Bolzoni; Valentina Tessoni; Maria Groppi; Giulio A De Leo
Journal:  J Math Biol       Date:  2013-09-22       Impact factor: 2.259

2.  Control with uncertain data of socially structured compartmental epidemic models.

Authors:  Giacomo Albi; Lorenzo Pareschi; Mattia Zanella
Journal:  J Math Biol       Date:  2021-05-23       Impact factor: 2.259

3.  Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty.

Authors:  Amy L Greer; Dena Schanzer
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

4.  Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocol.

Authors:  Luis R Carrasco; Mark Jit; Mark I Chen; Vernon J Lee; George J Milne; Alex R Cook
Journal:  Emerg Themes Epidemiol       Date:  2013-05-07

5.  Different types of door-opening motions as contributing factors to containment failures in hospital isolation rooms.

Authors:  Julian W Tang; Andre Nicolle; Jovan Pantelic; Christian A Klettner; Ruikun Su; Petri Kalliomaki; Pekka Saarinen; Hannu Koskela; Kari Reijula; Panu Mustakallio; David K W Cheong; Chandra Sekhar; Kwok Wai Tham
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

6.  Pandemic Risk Assessment Model (PRAM): a mathematical modeling approach to pandemic influenza planning.

Authors:  D C Dover; E M Kirwin; N Hernandez-Ceron; K A Nelson
Journal:  Epidemiol Infect       Date:  2016-08-22       Impact factor: 4.434

7.  Assessment of intensive vaccination and antiviral treatment in 2009 influenza pandemic in Korea.

Authors:  Chaeshin Chu; Sunmi Lee
Journal:  Osong Public Health Res Perspect       Date:  2014-12-24

8.  Optimal control strategy for abnormal innate immune response.

Authors:  Jinying Tan; Xiufen Zou
Journal:  Comput Math Methods Med       Date:  2015-04-08       Impact factor: 2.238

9.  Design of non-pharmaceutical intervention strategies for pandemic influenza outbreaks.

Authors:  Dayna L Martinez; Tapas K Das
Journal:  BMC Public Health       Date:  2014-12-29       Impact factor: 3.295

10.  Modeling optimal treatment strategies in a heterogeneous mixing model.

Authors:  Seoyun Choe; Sunmi Lee
Journal:  Theor Biol Med Model       Date:  2015-11-25       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.